Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06697925 · ClinicalTrials.gov registry record

Evaluating the Durability of Closure for Venous Leg Ulcers

A clinical trial of Venous Leg Ulcer and Venous Ulcer, sponsored by Kerecis.

Recruiting
Registry status
150
Enrollment target
1
Study location

NCT06697925 is a study of Venous Leg Ulcer and Venous Ulcer that is actively recruiting participants, run by Kerecis. The registered enrollment target is 150 participants, below the 241-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06697925, a study of Venous Leg Ulcer and Venous Ulcer, is actively recruiting participants, sponsored by Kerecis.

RECRUITING
Registry status
150 participants
Enrollment target
1
Study location

Study Summary

The goal of this observational study is to determine the durability of closure for venous leg ulcer subjects that achieved closure in the THOR trial.

Study Locations (1)

Pennsylvania

  • Serena Group - Monroeville

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2025-01
Est. Completion 2026-12

Sponsor

Kerecis

7 total trials

What the Registry Record Tells You About NCT06697925

The ClinicalTrials.gov registry entry for NCT06697925 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 241-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (38% lower). The listed sponsor is Kerecis, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Venous Leg Ulcer appearing as the primary indexed condition, and to 0 interventions.

NCT06697925 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06697925 about?

NCT06697925 is a clinical study titled "Evaluating the Durability of Closure for Venous Leg Ulcers". The goal of this observational study is to determine the durability of closure for venous leg ulcer subjects that achieved closure in the THOR trial.

What is the current status of trial NCT06697925?

This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2025-01. Estimated completion is 2026-12.

What conditions does trial NCT06697925 study?

This clinical trial studies the following conditions: Venous Leg Ulcer, Venous Ulcer, Venous Leg Ulcer (VLU), Venous Leg, VLU.

Who is sponsoring clinical trial NCT06697925?

This trial is sponsored by Kerecis, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06697925 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Venous Leg Ulcer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.